Keith Katkin

Keith Katkin has an estimated net worth of $18.2 Million. This is based on reported shares across multiple companies, which include RIGEL PHARMACEUTICALS INC, Carbylan Therapeutics, Inc., Syndax Pharmaceuticals Inc, Emergent BioSolutions Inc., Urovant Sciences Ltd., Eledon Pharmaceuticals, Inc., and AVANIR PHARMACEUTICALS, INC..

2022 was Keith Katkin's most active year for acquiring shares with 11 total transactions. Keith Katkin's most active month to acquire stocks was the month of April. 2010 was Keith Katkin's most active year for disposing of shares, totalling 38 transactions. Keith Katkin's most active month to dispose stocks was the month of December. 2020 saw Keith Katkin paying a total of $694,800.00 for 644,587.15 shares, this is the most they've acquired in one year. In 2014 Keith Katkin cashed out on 1,370,751 shares for a total of $7,295,959.84, their largest year based on trade value.